A detailed history of Peak6 LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Peak6 LLC holds 271,700 shares of LLY stock, worth $229 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
271,700
Holding current value
$229 Million
% of portfolio
0.46%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$727.2 - $932.06 $4.87 Million - $6.24 Million
6,693 New
6,693 $5.17 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $802B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.